You are here: Industry Insights > acquisition

News List

Cipla acquires stake in GoApptiv expresspharma
June 10, 2020
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages.
Ajinomoto Bio-Pharma Completes Acquisition of Granules OmniChem Joint Venture in India americanpharmaceuticalreview
June 03, 2020
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline expresspharma
May 18, 2020
The acquisition provides assets targeting tumour stroma and myeloid cells.
AbbVie completes acquisition of Allergan expresspharma
May 14, 2020
The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in immunology.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.
The Carlyle Group to acquire majority stake in SeQuent Scientific expresspharma
May 11, 2020
The transaction is expected to close in the third quarter of 2020, subject to customary closing conditions and regulatory approvals.
Sartorius Closes Acquisition of Danaher Life Sciences Selected Assets americanpharmaceuticalreview
May 07, 2020
Sartorius has closed the acquisition of selected life science businesses of Danaher Corporation. The transaction was completed on April 30, 2020, after receiving the required regulatory approvals.
Adare Pharma Acquires Orbis Biosciences contractpharma
May 07, 2020
Expands Adare’s technology platforms and product development capabilities.
FTC Clears AbbVie’s Acquisition of Allergan contractpharma
May 07, 2020
Only one Allergan director will join the AbbVie board after close.
Alexion to buy biopharmaceutical firm Portola in $1.41bn deal pharmaceutical-business-review
May 06, 2020
Alexion Pharmaceuticals has signed an agreement to acquire commercial-stage biopharmaceutical company Portola in a deal valued at around $1.41bn.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page